University of Chicago, DCAM
Welcome,         Profile    Billing    Logout  
 3 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rubin, David
COMPASS-CD, NCT04809363: A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

Active, not recruiting
4
200
US
CDPATH™, PROSPECT, Blood Draw
Takeda
Crohn's Disease
10/25
06/26
NCT06045754: A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Recruiting
4
150
Canada, US
Vedolizumab, Entyvio, Adalimumab, Humira, Ustekinumab, Stelara
Takeda
Crohn's Disease
06/27
06/27
NCT06095128: A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Recruiting
4
65
Canada, US
Vedolizumab, Entyvio, MLN0002, Tofacitinib, Xeljanz, CP-690, CP-550
Takeda
Ulcerative Colitis
07/27
07/27
ABX464-106, NCT05507216: ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

Recruiting
3
612
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
03/25
04/25
ABTECT, NCT05535946: - Maintenance

Recruiting
3
1050
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
01/26
01/30
NCT03648710: Community Health Workers and mHealth for Sickle Cell Disease Care

Completed
N/A
405
US
Peer Community Health Worker, Mobile Health
Children's Hospital of Philadelphia, St. Christopher's Hospital for Children, Children's Hospital Medical Center, Cincinnati, Steven and Alexandra Cohen Children's Medical Center, Connecticut Children's Medical Center, Patient-Centered Outcomes Research Institute
Sickle Cell Disease
08/24
08/24
NCT06575660: Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease

Recruiting
N/A
28
US
Mental health support session
University of Chicago, Cedars-Sinai Medical Center
Inflammatory Bowel Diseases, Anxiety, Depression, Ulcerative Colitis, Crohn Disease
09/25
09/25
NCT06693310: STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission

Not yet recruiting
N/A
200
US
de-escalation or discontinuation of therapy, continuation of current therapy
University of Chicago
Ulcerative Colitis (UC)
01/26
01/27
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting
N/A
600
US
No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment
Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research
HIV Infections, Multi-Antiviral Resistance
06/25
12/25
QUOTIENT, NCT05230173: Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Recruiting
N/A
250
US
Pragmatic
University of California, San Diego, Baylor College of Medicine, Crohn's and Colitis Foundation, Western University, Patient-Centered Outcomes Research Institute
Ulcerative Colitis, Crohn Disease
03/28
06/28
Surma, Bonnie
No trials found

Download Options